|
ISPOR 8th Annual European Congress Scientific Awards Winners
Stephen L. Priori, Director, ISPOR Publications
 One of ISPOR’s objectives (as stated at:
http://www.ispor.org/mission.asp) is to provide
recognition of individual achievement in the field of
pharmacoeconomics and outcomes research. A new procedure for
recognizing the recipients of the ISPOR BEST CONTRIBUTED
PRESENTATION AWARDS was implemented at the ISPOR 8th Annual
European Congress. Recipients (and their papers) are recognized
to a larger audience via the ISPOR website. For ISPOR
CONTRIBUTED PRESENTATION AWARD CATEGORIES, CRITERIA, SELECTION
PROCESS, see:http://www.ispor.org/awards/podiumcriteria_.asp and
http://www.ispor.org/awards/postercriteria_.asp.
The RECIPIENTS
OF THE ISPOR 8TH ANNUAL EUROPEAN CONGRESS BEST CONTRIBUTED
PRESENTATION AWARDS are:
ISPOR Best Contributed
Podium Presentation Award
BEST GENERAL PODIUM PRESENTATIONS
CN3 HEALTH ECONOMIC EVALUATION BASED ON THE 5-YEAR COMPLETED
TREATMENT ANALYSIS OF THE ATAC TRIAL COMPARING ANASTROZOLE VERSUS TAMOXIFEN
IN ADJUVANT TREATMENT OF POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE EARLY
BREAST CANCER
Moeremans K, Annemans L
IMS Health, Brussels, Belgium
DN2 COST-UTILITY ANALYSIS IN A UK SETTING OF SELF MONITORING OF BLOOD
GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES
Palmer AJ1, Dineen S2, Gavin III JR3, Gray A4, Herman WH5, Karter AJ6
1CORE - Center for Outcomes Research, Binningen, Switzerland; 2National
University of Ireland, Galway, Galway, Ireland; 3Emory University School of
Medicine and Morehouse School of Medicine, Fairburn, GA, USA; 4University of
Oxford, Oxford, United Kingdom; 5University of Michigan, Ann Arbor, MI, USA;
6Kaiser Permanente, Oakland, CA, USA
UH4 CHARACTERISTICS RELATED TO PRODUCTIVITY LOSS IN PATIENTS WITH
OVERACTIVE BLADDER: RESULTS FROM THE MATRIX STUDY
Pizzi LT1, Gemmen E2, Dahl NV3
1Jefferson Medical College, Philadelphia, PA, USA; 2Quintiles, Falls Church,
VA, USA; 3Watson Laboratories, Morristown, NJ, USA
BEST NEW INVESTIGATOR PODIUM PRESENTATIONS
PR4 PATIENT PREFERENCE AND WILLINGNESS-TO-PAY FOR ANTICOAGULANT TREATMENT
OPTIONS IN PATIENTS RECEIVING ORAL ANTICOAGULANT TREATMENT (OAT): A CONJOINT
ANALYSIS EXERCISE
Monzini M1, Carpenedo M2, Moia M2, Mantovani LG1
1Center of Pharmacoeconomics, Milan, Italy; 2IRCCS Maggiore Hospital and
University of Milan, Milan, Italy
CV1 A TRIAL BASED PACING DECREASES ATRIAL FIBRILLATION RELATED
HOSPITALIZATIONS AND COSTS IN BRADY-TACHY SYNDROME
Ruciński P1, Kutarski A1, Latek M2, Kamiński B2, Szczasny M1,
Widomska-Czekajska T1, Wdowiak L1
1Medical University of Lublin, Lublin, Lubelskie, Poland; 2Warsaw School of
Economics, Warszawa, Mazowieckie, Poland
HP6 EFFECT OF CO-PAYMENT ON COMPLIANCE TO STATINS AFTER CORONARY HEART
DISEASE HOSPITALIZATION
Ye X, St.Peter WL, Gross CR
University of Minnesota, Minneapolis, MN, USA
BEST STUDENT PODIUM PRESENTATIONS
PO1 TRAJECTORIES OF EQ-5D QUALITY OF LIFE UTILITY SCORES FOR 10,000
SCHIZOPHRENIA OUTPATIENTS OVER 2 YEARS: A REPORT FROM THE SOHO STUDY
Hammond GC1, Croudace TJ1, Jones PB1, Belger M2, Novick D2
1University of Cambridge, Cambridge, UK; 2Eli Lilly and Company Ltd,
Windlesham, Surrey, UK
QL2 TESTING THE CROSS-WALK: SALVAGING CANCER SPECIFIC MEASURES FOR USE IN
ECONOMIC EVALUATION
Wilson TR1, Kind P2
1University of York, York, UK; 2Outcomes Research Group, York, UK
QL8 QUALITY OF LIFE IN HEMOPHILIC PATIENTS WITHOUT INHIBITORS: THE COCHE
STUDY
Scalone L1, Gringeri A2, Von Mackensen S3, Mannucci PM2, De Silvio S1,
Anastasia M1, Di Stasi F1, Mantovani LG1
1University of Milan, Milan, Italy; 2Haemophilia and Thrombosis Centre,
Milan, Italy; 3Institute for Medical Psychology, Hamburg, Germany
ISPOR Best Contributed Poster Presentation
BEST GENERAL POSTER PRESENTATIONS
PMH3
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN GROWN-UPS: ADMINISTRATIVE
DATA ON CO-EXISTING CONDITIONS
Schlander M1, Schwarz O1, Trott GE1, Viapiano M2, Bonauer N2
1Institute for Innovation & Valuation in Health Care (InnoVal-HC), Eschborn,
Germany; 2Kassenaerztliche Vereinigung Baden-Wuerttemberg, Karlsruhe,
Germany
PMH34 LONG-TERM TREATMENT OF SCHIZOPHRENIA FOR RELAPSE PREVENTION (LASER):
6-MONTH OUTCOMES IN PATIENTS STARTED ON RISPERIDONE LONG-ACTING INJECTABLE
IN GERMANY - DATA FROM THE E-STAR DATABASE
Naber D1, Mehnert A2, Rosillon D3, Farmer D4, Schreiner A2, Jacobs A5
1Department of Psychiatry and Psychotherapy, Hamburg, Germany;
2Janssen-Cilag GmbH, Neuss, Germany; 3SGS Biopharma, Wavre, Belgium;
4Interactive Educational Systems, Ltd, Hampton Court, Surrey, United
Kingdom; 5Janssen Pharmaceutica NV, Beerse, Belgium
PHP7 MANAGING ACUTE INJURIES RESULTING FROM MOTORCYCLE ACCIDENTS: EMERGENCY
DEPARTMENT AND INPATIENT HOSPITAL RESOURCE USE AND COSTS
O'Brien JA1, Pitoniak-Morse C1, Jacobs LM2
1Caro Research Institute, Concord, MA, USA; 2University of Connecticut
Medical School, Farmington, CT, USA
BEST NEW INVESTIGATOR POSTER PRESENTATIONS
PCV3 A PHARMACO-ECONOMIC EVALUATION OF AGGRESSIVE CHOLESTEROL LOWERING
AFTER ACUTE CORONARY SYNDROME IN BELGIUM: A SHORT-TERM AND LONG-TERM
ASSESSMENT
Annemans L1, Van Campenhout H2, Matthys K2, Casciano RN3, Budts W4
1IMS Health, Brussels, Belgium; 2Pfizer, Brussels, Belgium; 3Analytica
International, Loerrach, Germany; 4UZ Gasthuisberg, Leuven, Belgium
PCV58 COST-EFFECTIVENESS OF INDAPAMIDE IN PATIENTS WITH MILD-TO-MODERATE
HYPERTENSION
Stafylas PC1, Sarafidis PA1, Lasaridis AN1, Aletras VH2
1AHEPA University Hospital, Thessaloniki, Greece; 2University of Macedonia,
Thessaloniki, Greece
PSN23 FACTORS INFLUENCING QUALITY OF LIFE IN ATOPIC DERMATITIS
Hampson NE1, Meads DM1, McKenna SP1, Doward LC1, Turk F2
1Galen Research, Manchester, Manchester, UK; 2Novartis Pharma AG, Basel,
Switzerland
BEST STUDENT POSTER PRESENTATIONS
PMH44 DULOXETINE AND VENLAFAXINE-XR IN THE TREATMENT OF MDD: A
META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
Vis PM1, van Baardewijk M2, Einarson T3
1Univeristy of Utrecht, Utrecht, Netherlands; 2Univeristy of Utrecht,
Utrecht, Utrecht, Netherlands; 3 University of Toronto, Toronto, ON, Canada
PMH45 COST EFFECTIVENESS OF DULOXETINE COMPARED WITH VENLAFAXINE-XR IN
THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
Van Baardewijk M1, Vis PM1, Einarson T2
1Univeristy of Utrecht, Utrecht, Netherlands; 2University of Toronto,
Toronto, ON, Canada
PRS8 COST-EFFECTIVENESS OF FLUTICASONE PROPIONATE NASAL DROPS VERSUS
SURGICAL TREATMENT FOR NASAL POLYPOSIS IN POLAND
Golicki D1, Latek M2, Niewada M1, Glogowski C3, Kukwa W1, Macioch T1
1Medical University of Warsaw, Warsaw, Poland; 2Warsaw School of Economics,
Warsaw, Poland; 3GlaxoSmithKline Pharmaceuticals S.A, Warsaw, Poland
A special thanks goes to all the judges, the ISPOR Annual European
Congress Awards Task Force Chairs as well as the ISPOR Awards Committee
Chair who volunteered their time and efforts in selecting the winners.
ISPOR ANNUAL EUROPEAN CONGRESS AWARDS TASK FORCE
CHAIRS:
Podium:
Hans L. Severens, PhD, University Maastricht, Maastricht, The
Netherlands
Poster: Pedro Plans-Rubio, G.D.
Public Health, Department de Sanitat, Sant Pol, Spain
ISPOR JUDGES:
Carl Asche MBA, MSc, PhD; Rajesh Balkrishnan MS, PhD; Florence
Baron-Papillon; Rami Ben-Joseph PhD, RPh; Gilles Berdeaux MD, PhD; Pascale
Brasseur MBA; Ruth Brown MS; Anita Burrell MBA; Supatra Chadbunchachai BSc,
MPH, PhD; Mary Cifaldi RPh; Ami Claxton MS, PhD; Lynda Doward; Dogan Fidan
MD, MSc, PhD; Duska Franic PharmD, PhD; Tom Goss PharmD; Holger Gothe MA,
MD; Wolfgang Habacher MSc; Magda Hatzikou BSc, MBA; Michael Iskedjian MSc,
RPh; Ian Johnson; Tim KirMBA; Antoine Lafuma MD; Marie-Noelle Lazaridou;
KatellLe Lay MA; Nicky Liebermann MD; Josephine Li-McLeod; Andrew Lloyd PhD;
Vittorio Maio MS, PharmD; Farzana Malik PhD; Charles Makin MS; Bradley
Martin PharmD, PhD, RPh; Susan Mathias MPH; Karolina Minda MSc; Anant Murthy
MSc; Marko Mychaskiw BS, MS, PhD, RPh; Michael Ortiz BSc, MSc, PhD, RPh;
Anhoury Pierre MD; Andrew Peterson PharmD; Olaf Pirk MD; Jonathan Plumb BSc,
MSc; Yogesh Punekar MBA, PhD; Karen Rascati PhD, RPh; Barbara Rohan MS;
Maureen Rutten; Joseph Singer MD; Agnieszka Skowron; Dong-churl Suh MBA,
PhD; Hans Tamminga PhD; Gabriela Tannus MBA; F. Cankat Tulunay MD, PhD;
Birgitt von Scheele MS; Michael Wang; Vladimir Zah; Giovanni Zanotti
|
